VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1559696
Sex: F
Age: 71
State: NM

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Sleepy; Terrible Fatigue; Could not get out of bed; Headache; Not feel good at all; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache) and MALAISE (Not feel good at all). On 10-Feb-2021, the patient experienced CHILLS (Chills) and SOMNOLENCE (Sleepy). At the time of the report, FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all), CHILLS (Chills) and SOMNOLENCE (Sleepy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559697
Sex: M
Age:
State: IL

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were reported No concomitant medications were reported

Other Meds:

Current Illness:

ID: 1559698
Sex: F
Age:
State: OK

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-031421 (Patient Link).

Other Meds:

Current Illness:

ID: 1559699
Sex: U
Age: 45
State:

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body pain; pain in injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN and INJECTION SITE PAIN in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN and INJECTION SITE PAIN. At the time of the report, PAIN and INJECTION SITE PAIN outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559700
Sex: M
Age: 89
State:

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Started with involuntary jerking of his right arm; m Friday night started involuntary muscle spasms of the right leg more like a jerking motion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion) and DYSKINESIA (Started with involuntary jerking of his right arm) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in January 2021. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion). On 08-Feb-2021, the patient experienced DYSKINESIA (Started with involuntary jerking of his right arm). At the time of the report, MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion) and DYSKINESIA (Started with involuntary jerking of his right arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559701
Sex: F
Age: 34
State: IL

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: big, itchy rash at the injection site; very large lymph node on their neck.; their neck hurt a little; Little arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included BISACODYL (LAXATIN), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and VITAMINS NOS for an unknown indication. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little arm soreness). On 07-Feb-2021, the patient experienced NECK PAIN (their neck hurt a little). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.). At the time of the report, PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details was not reported by the reporter.

Other Meds: LAXATIN; WELLBUTRIN; VITAMINS NOS

Current Illness:

ID: 1559702
Sex: F
Age: 85
State: NC

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; A spontaneous report was received from a consumer concerning a 85-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm. The patient's medical history was not provided. No relevant concomitant medications were reported. On 19 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) sore arm. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported./unknown The outcome of event(s), sore arm was unknown.

Other Meds:

Current Illness:

ID: 1559703
Sex: F
Age: 68
State: NY

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: discomfort; vertigo; dry heaves; dizziness; hot flashes; chills; nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, and HOT FLUSH in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Vertigo. Concomitant products included METOPROLOL, NEXIUM, DITROPAN, Losartan/ HCTZ, METHENAMINE, REPATHA, JANUVIA, VITAMIN D3, and VITAMIN C for an unknown indication. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, NAUSEA, and FATIGUE. On 04-Feb-2021, DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, and NAUSEA had resolved. On 06-Feb-2021, FATIGUE had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details included none.

Other Meds: METOPROLOL; NEXIUM; DITROPAN; Losartan/ HCTZ; METHENAMINE; REPATHA; JANUVIA; VITAMIN D 3; VITAMIN C

Current Illness:

ID: 1559704
Sex: F
Age: 53
State: OH

Vax Date: 01/14/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed shingles on her right abdomen; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Developed shingles on her right abdomen) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HERPES ZOSTER (Developed shingles on her right abdomen). At the time of the report, HERPES ZOSTER (Developed shingles on her right abdomen) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559705
Sex: F
Age:
State: AK

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle weakness at site of injection; could not move the arm; extreme pain at the site of injection / extreme pain on left arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 012M20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma and Blood pressure high. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN. At the time of the report, INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications reported were blood pressure medicine and asthma medicine. Treatment information were reported as patient went to the doctor and got a pain shot and took medicines.

Other Meds:

Current Illness: Asthma; Blood pressure high

ID: 1559706
Sex: F
Age: 75
State: CA

Vax Date: 01/31/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: little pain at injection site; redness and itching at the injection site; itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness and itching at the injection site) and VACCINATION SITE PAIN (little pain at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site). On 07-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and itching at the injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (little pain at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness and itching at the injection site) and VACCINATION SITE PAIN (little pain at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1559707
Sex: F
Age: 83
State: FL

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; Swollen; Left arm is painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Left arm is painful) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LOSARTAN and ATORVASTATIN for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Left arm is painful). At the time of the report, VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Left arm is painful) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product also included thyroid medication. Treatment information was not provided. Patient reported that the reactions have gotten worse since she received the vaccine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds: LOSARTAN; ATORVASTATIN

Current Illness: Thyroid disorder NOS

ID: 1559708
Sex: F
Age:
State:

Vax Date: 02/03/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: It's warm to the touch; Redness; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (It's warm to the touch), ERYTHEMA (Redness) and PRURITUS (Itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (It's warm to the touch), ERYTHEMA (Redness) and PRURITUS (Itching). At the time of the report, VACCINATION SITE WARMTH (It's warm to the touch), ERYTHEMA (Redness) and PRURITUS (Itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details was not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1559709
Sex: F
Age: 73
State: CA

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Problem with balance; Stomach issues; Loss of bladder control at night; Really bad muscle problems; Neckache; she was on the floor; She felt extraordinary dizzy; Severe nausea; Headache; She also had chills; Extreme muscle and joint pain; inability to eat; Really bad joint problems, every joint in her body hurt/ joint pain; She felt terrible/ extreme distress; Fever 101, 102 for 3 days/ high fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEEDING DISORDER (inability to eat), DIZZINESS (She felt extraordinary dizzy), FEELING ABNORMAL (She felt terrible/ extreme distress), BALANCE DISORDER (Problem with balance) and ABDOMINAL DISCOMFORT (Stomach issues) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Immunoglobulin therapy (she needs an IG booster her immune system) and Back surgery (Back surgery). Previously administered products included for Drug use for unknown indication: Levofloxacin and paroxetine. Past adverse reactions to the above products included Anaphylaxis with Levofloxacin and paroxetine. Concurrent medical conditions included Mastocytosis, Parvovirus infection, Sinus disorder, Back pain, Autoimmune disorder NOS, Drug allergy (Levaquin allergy), Drug allergy (Ceclor allergy), Drug allergy (Paxil allergy) and Allergy. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for Allergy, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Back pain, DOXEPIN for Hives, GABAPENTIN for Nerve pain. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced FEEDING DISORDER (inability to eat), FEELING ABNORMAL (She felt terrible/ extreme distress), PYREXIA (Fever 101, 102 for 3 days/ high fever), ARTHRALGIA (Really bad joint problems, every joint in her body hurt/ joint pain) and MYALGIA (Extreme muscle and joint pain). On 11-Feb-2021, the patient experienced DIZZINESS (She felt extraordinary dizzy), BALANCE DISORDER (Problem with balance), ABDOMINAL DISCOMFORT (Stomach issues), URINARY INCONTINENCE (Loss of bladder control at night), MUSCLE DISCOMFORT (Really bad muscle problems), NECK PAIN (Neckache), FALL (she was on the floor), NAUSEA (Severe nausea), HEADACHE (Headache) and CHILLS (She also had chills). On 12-Feb-2021, FEEDING DISORDER (inability to eat), FEELING ABNORMAL (She felt terrible/ extreme distress), PYREXIA (Fever 101, 102 for 3 days/ high fever), ARTHRALGIA (Really bad joint problems, every joint in her body hurt/ joint pain) and MYALGIA (Extreme muscle and joint pain) had resolved. At the time of the report, DIZZINESS (She felt extraordinary dizzy), BALANCE DISORDER (Problem with balance), ABDOMINAL DISCOMFORT (Stomach issues), URINARY INCONTINENCE (Loss of bladder control at night), MUSCLE DISCOMFORT (Really bad muscle problems), NECK PAIN (Neckache), FALL (she was on the floor), NAUSEA (Severe nausea), HEADACHE (Headache) and CHILLS (She also had chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 101 High and 102 High. On 15-Feb-2021, Heart rate: elevated High. Treatment details included a lot of tylenol, liquid sulpha drugs, 1 pill of Propanolol. This case was linked to MOD-2021-129168 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: updated patient history, concomitant medications and new events.

Other Meds: CYMBALTA; DOXEPIN; SINGULAIR; GABAPENTIN

Current Illness: Allergy; Autoimmune disorder NOS; Back pain; Drug allergy (Paxil allergy); Drug allergy (Levaquin allergy); Drug allergy (Ceclor allergy); Mastocytosis; Parvovirus infection; Sinus disorder

ID: 1559710
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: so dizzy; Chills; Fever; bedridden for two days; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS, CHILLS, PYREXIA, and BEDRIDDEN in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included VITAMINS for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS, CHILLS, PYREXIA, and BEDRIDDEN. The patient was treated with TYLENOL at a dose of UNK dosage form. At the time of the report, DIZZINESS, CHILLS, PYREXIA, and BEDRIDDEN outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: VITAMINS

Current Illness:

ID: 1559711
Sex: F
Age:
State: MD

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Numb cheek; Left arm was weak; left vision was messed up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Numb cheek), MUSCULAR WEAKNESS (Left arm was weak) and VISUAL IMPAIRMENT (left vision was messed up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13L20X-4) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HYPOAESTHESIA (Numb cheek), MUSCULAR WEAKNESS (Left arm was weak) and VISUAL IMPAIRMENT (left vision was messed up). On 03-Feb-2021, HYPOAESTHESIA (Numb cheek), MUSCULAR WEAKNESS (Left arm was weak) and VISUAL IMPAIRMENT (left vision was messed up) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1559712
Sex: F
Age: 73
State: NY

Vax Date: 02/05/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen rash; Rash that has not gone away for three days/swollen rash; covid arm; red splotch; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash that has not gone away for three days/swollen rash), PAIN IN EXTREMITY (covid arm), RASH MACULAR (red splotch) and RASH (Swollen rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash that has not gone away for three days/swollen rash), PAIN IN EXTREMITY (covid arm) and RASH MACULAR (red splotch). On an unknown date, the patient experienced RASH (Swollen rash). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at a dose of UNK dosage form, qd. On 19-Feb-2021, RASH (Rash that has not gone away for three days/swollen rash), PAIN IN EXTREMITY (covid arm) and RASH MACULAR (red splotch) had resolved. At the time of the report, RASH (Swollen rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported Treatment medication used was topical ointment. Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: No specific follow-up information recorded. On 18-May-2021: ADR, form with page 1 and 2 was received.

Other Meds:

Current Illness:

ID: 1559713
Sex: F
Age: 59
State: VA

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tenderness in her left under arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in her left under arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced TENDERNESS (Tenderness in her left under arm). At the time of the report, TENDERNESS (Tenderness in her left under arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1559714
Sex: F
Age: 77
State: CT

Vax Date: 01/28/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 2-2 1/2 inch spot that reds; felt like a black and blue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2OA) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue). At the time of the report, VACCINATION SITE ERYTHEMA (2-2 1/2 inch spot that reds) and INJECTION SITE BRUISING (felt like a black and blue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medications:- Arnica cream Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Updated events outcome as recovered/resolved.

Other Meds:

Current Illness:

ID: 1559715
Sex: F
Age: 49
State: CA

Vax Date: 01/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; nausea; still lite headiness; Pain at the Injection Site; felt very sick; fever; migraine; chills; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN, MALAISE, PYREXIA, MIGRAINE, and CHILLS in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Cancer (post breads cancer). Concomitant products included EXCEDRIN for an unknown indication, TAMOXIFEN. On 12-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN, MALAISE, PYREXIA, MIGRAINE, and CHILLS. On an unknown date, the patient experienced MYALGIA, NAUSEA, and DIZZINESS. The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form and TYLENOL ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN, MALAISE, PYREXIA, MIGRAINE, CHILLS, NAUSEA, and DIZZINESS outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: TAMOXIFEN; EXCEDRIN

Current Illness:

ID: 1559716
Sex: F
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days; hot to touch, looked like top of my arm was sunburned; itching; blossomed with this hot red; ear all swollen inside and throbbing; right arm broke out in eczema; all the anxiety went with it,feels like my whole body is filled with histamine; left eyelid goes almost non stop all day and it twitches; felt like there was a drainage in ears; all kinds of weird things on my body; issues with everything on my left side; my body went whacky after I got the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red) and EAR SWELLING (ear all swollen inside and throbbing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History Information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red), EAR SWELLING (ear all swollen inside and throbbing), ECZEMA (right arm broke out in eczema), ANXIETY (all the anxiety went with it,feels like my whole body is filled with histamine), BLEPHAROSPASM (left eyelid goes almost non stop all day and it twitches), DRAINAGE (felt like there was a drainage in ears), FEELING ABNORMAL (all kinds of weird things on my body), DISCOMFORT (issues with everything on my left side) and FEELING ABNORMAL (my body went whacky after I got the vaccine). At the time of the report, VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red), EAR SWELLING (ear all swollen inside and throbbing), ECZEMA (right arm broke out in eczema), ANXIETY (all the anxiety went with it,feels like my whole body is filled with histamine), BLEPHAROSPASM (left eyelid goes almost non stop all day and it twitches), DRAINAGE (felt like there was a drainage in ears), FEELING ABNORMAL (all kinds of weird things on my body), DISCOMFORT (issues with everything on my left side) and FEELING ABNORMAL (my body went whacky after I got the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient went to her doctor for the reported events. Patient was given topical cream for the symptoms. No relevant Concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 17-Feb-2021. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red) and EAR SWELLING (ear all swollen inside and throbbing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History Information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red), EAR SWELLING (ear all swollen inside and throbbing), ECZEMA (right arm broke out in eczema), ANXIETY (all the anxiety went with it,feels like my whole body is filled with histamine), BLEPHAROSPASM (left eyelid goes almost non stop all day and it twitches), DRAINAGE (felt like there was a drainage in ears), FEELING ABNORMAL (all kinds of weird things on my body), DISCOMFORT (issues with everything on my left side) and FEELING ABNORMAL (my body went whacky after I got the vaccine). At the time of the report, VACCINATION SITE RASH (rash on my arm in the injection site 2 weeks after the injection, rash went away after 5 days), VACCINATION SITE PAIN (hot to touch, looked like top of my arm was sunburned), PRURITUS (itching), ERYTHEMA (blossomed with this hot red), EAR SWELLING (ear all swollen inside and throbbing), ECZEMA (right arm broke out in eczema), ANXIETY (all the anxiety went with it,feels like my whole body is filled with histamine), BLEPHAROSPASM (left eyelid goes almost non stop all day and it twitches), DRAINAGE (felt like there was a drainage in ears), FEELING ABNORMAL (all kinds of weird things on my body), DISCOMFORT (issues with everything on my left side) and FEELING ABNORMAL (my body went whacky after I got the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient went to her doctor for the reported events. Patient was given topical cream for the symptoms. No relevant Concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI

Other Meds:

Current Illness:

ID: 1559717
Sex: F
Age: 73
State:

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: was very tired and is still tired; arm was also sore; She felt lousy like she did not want to do anything; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (was very tired and is still tired), PAIN IN EXTREMITY (arm was also sore) and MALAISE (She felt lousy like she did not want to do anything) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 04-Feb-2021, the patient experienced FATIGUE (was very tired and is still tired), PAIN IN EXTREMITY (arm was also sore) and MALAISE (She felt lousy like she did not want to do anything). At the time of the report, FATIGUE (was very tired and is still tired), PAIN IN EXTREMITY (arm was also sore) and MALAISE (She felt lousy like she did not want to do anything) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not provided. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1559718
Sex: F
Age: 71
State:

Vax Date: 01/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain at injection site; fatigue; fever reemerged; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and PYREXIA (fever reemerged) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and PYREXIA (fever reemerged). On 09-Feb-2021, VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and PYREXIA (fever reemerged) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported Treatment details included acetaminophen.

Other Meds:

Current Illness:

ID: 1559719
Sex: U
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: persistent headaches; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEADACHE (persistent headaches) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (persistent headaches). At the time of the report, HEADACHE (persistent headaches) outcome was unknown. Related The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559720
Sex: F
Age:
State: OH

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Nauseated; Joint pain; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PYREXIA (Fever), NAUSEA (Nauseated) and ARTHRALGIA (Joint pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nauseated) and ARTHRALGIA (Joint pain). On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, DIARRHOEA (Diarrhea), PYREXIA (Fever), NAUSEA (Nauseated) and ARTHRALGIA (Joint pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559721
Sex: F
Age: 69
State: CA

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red mark on the patient's arm the size of a quarter; Stiffness in arm; My left arm was swollen; Soreness in their arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen), VACCINATION SITE PAIN (Soreness in their arm) and VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Compazine) and Allergy to vaccine (Shingles shot). Concomitant products included SIMVASTATIN (ZOCOR), METFORMIN HCL, ESTRADIOL (YUVAFEM), METOPROLOL SUCCINATE (TOPROL XL) and TRAVOPROST for an unknown indication. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen) and VACCINATION SITE PAIN (Soreness in their arm). On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter). On 25-Feb-2021, MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen) and VACCINATION SITE PAIN (Soreness in their arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Treatment for the events were not provided. This case was linked to MOD-2021-235593 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Patient demographics, medical history, concomitant medications updated. Additional event was added.Start date and stop date for the events updated.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: ZOCOR; METFORMIN HCL; YUVAFEM; TOPROL XL; TRAVOPROST

Current Illness: Allergy to vaccine (Shingles shot); Drug allergy (Compazine)

ID: 1559722
Sex: F
Age:
State: MO

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body shaking; Diarrhea; high blood pressure; pain; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (body shaking), DIARRHOEA (Diarrhea), BLOOD PRESSURE INCREASED (high blood pressure) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced TREMOR (body shaking), DIARRHOEA (Diarrhea), BLOOD PRESSURE INCREASED (high blood pressure) and PAIN (pain). At the time of the report, TREMOR (body shaking), DIARRHOEA (Diarrhea), BLOOD PRESSURE INCREASED (high blood pressure) and PAIN (pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559723
Sex: F
Age:
State: FL

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A little fatigued/tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (A little fatigued/tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced FATIGUE (A little fatigued/tired). At the time of the report, FATIGUE (A little fatigued/tired) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559724
Sex: M
Age:
State:

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme shakes; Vertigo; Mentally fuzzy; Sick; Extreme headache; Nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Extreme shakes), VERTIGO (Vertigo), FEELING ABNORMAL (Mentally fuzzy), ILLNESS (Sick) and HEADACHE (Extreme headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History was provided by the reporter. On 10-Feb-2021 at 9:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced TREMOR (Extreme shakes), VERTIGO (Vertigo), FEELING ABNORMAL (Mentally fuzzy), ILLNESS (Sick), HEADACHE (Extreme headache), NAUSEA (Nausea) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at a dose of 3 dosage form. At the time of the report, TREMOR (Extreme shakes), VERTIGO (Vertigo), FEELING ABNORMAL (Mentally fuzzy), ILLNESS (Sick), HEADACHE (Extreme headache), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 102 (High) Patient had fever of 102 F. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1559725
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Difficulty breathing after the Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing after the Moderna shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing after the Moderna shot). At the time of the report, DYSPNOEA (Difficulty breathing after the Moderna shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient's medical history and relevant concomitant medications weren't reported Treatment information was not provided Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1559726
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559727
Sex: F
Age: 69
State: PA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extremely sore arm,; had fatigue; muscle ache; headache; Immediately after receiving the shot she felt her throat was closing for a couple of seconds; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Immediately after receiving the shot she felt her throat was closing for a couple of seconds), PAIN IN EXTREMITY (extremely sore arm,), FATIGUE (had fatigue), MYALGIA (muscle ache) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concomitant products included METFORMIN, LISINOPRIL, LORAZEPAM, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) and MINERALS for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced THROAT TIGHTNESS (Immediately after receiving the shot she felt her throat was closing for a couple of seconds). On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (extremely sore arm,), FATIGUE (had fatigue), MYALGIA (muscle ache) and HEADACHE (headache). On 05-Feb-2021, THROAT TIGHTNESS (Immediately after receiving the shot she felt her throat was closing for a couple of seconds) had resolved. At the time of the report, PAIN IN EXTREMITY (extremely sore arm,), FATIGUE (had fatigue), MYALGIA (muscle ache) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included ibuprofen

Other Meds: METFORMIN; LISINOPRIL; LORAZEPAM; PRILOSEC [OMEPRAZOLE MAGNESIUM]; MINERALS

Current Illness:

ID: 1559728
Sex: F
Age: 35
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant patient; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant patient) in a 35-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The patient's past medical history included Pregnancy (ended in C sections). Concurrent medical conditions included Headache. Concomitant products included PARACETAMOL (TYLENOL) for Headache, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Dec-2020 to an unknown date for an unknown indication. On 17-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 22-Nov-2020 and the estimated date of delivery was 29-Aug-2021. On 17-Feb-2021, the patient experienced MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant patient). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twelfth week of the pregnancy. On 17-Feb-2021, MATERNAL EXPOSURE BEFORE PREGNANCY (Pregnant patient) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Nov-2020, Pregnancy test: positive (Positive) Positive. On 08-Feb-2021, Blood test: normal (normal) blood work within normal limits. On 08-Feb-2021, Ultrasound scan: 160 (High) Heart beat 160. On 12-Feb-2021, Blood test: normal (normal) blood work within normal limits. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient had conception on 06-Dec-2020. Number of fetus was found to be one. Treatment information was not provided.

Other Meds: TYLENOL; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness: Headache

ID: 1559729
Sex: F
Age: 69
State: FL

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever of 100.5; Shortness of breath; Jaw achy; Neck hurting; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy), NECK PAIN (Neck hurting) and PYREXIA (fever of 100.5) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication, OMALIZUMAB (XOLAIR). On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy) and NECK PAIN (Neck hurting). On 04-Feb-2021, the patient experienced PYREXIA (fever of 100.5). At the time of the report, DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy), NECK PAIN (Neck hurting) and PYREXIA (fever of 100.5) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5 F. Treatment details included Paracetamol and Naproxen.

Other Meds: SYMBICORT; XOLAIR

Current Illness:

ID: 1559730
Sex: F
Age:
State: CA

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The heated spot was hot, tender, and about 5 inches; heated spot was hot, tender, and about 5 inches; Tenderness and pressure/top left side of her head heated up; Head sore/tender on the side of head; The top left side of head heated up and was sore/Severe migraine; This spontaneous case was reported by a nurse and describes the occurrence of MIGRAINE, FEELING HOT, INFLAMMATION, HEAD DISCOMFORT, and HEADACHE in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced MIGRAINE. On 20-Jan-2021, the patient experienced FEELING HOT, INFLAMMATION, HEAD DISCOMFORT, and HEADACHE. On 19-Jan-2021, MIGRAINE had resolved. On 20-Jan-2021, FEELING HOT, INFLAMMATION, HEAD DISCOMFORT, and HEADACHE had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Advil. This case was linked to MOD21-026177 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up information received 27-APR-2021 on contains non-significant information; Sender's Comments: MOD21-026177:

Other Meds:

Current Illness:

ID: 1559731
Sex: F
Age: 76
State: TX

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blisters on the arm at the injection site after the first dose; Itching at the injection site after the first dose; Pain at the injection site after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters on the arm at the injection site after the first dose), INJECTION SITE PRURITUS (Itching at the injection site after the first dose) and VACCINATION SITE PAIN (Pain at the injection site after the first dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced BLISTER (Blisters on the arm at the injection site after the first dose), INJECTION SITE PRURITUS (Itching at the injection site after the first dose) and VACCINATION SITE PAIN (Pain at the injection site after the first dose). At the time of the report, BLISTER (Blisters on the arm at the injection site after the first dose), INJECTION SITE PRURITUS (Itching at the injection site after the first dose) and VACCINATION SITE PAIN (Pain at the injection site after the first dose) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant and treatment medication were not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1559732
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have had a very strong adverse reaction to the first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I have had a very strong adverse reaction to the first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 in December 2020. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I have had a very strong adverse reaction to the first shot). At the time of the report, VACCINATION COMPLICATION (I have had a very strong adverse reaction to the first shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1559733
Sex: F
Age: 69
State:

Vax Date: 01/28/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Warm (ring) on skin; Swelling; Bump (L) arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm (ring) on skin), SWELLING (Swelling), INJECTION SITE MASS (Bump (L) arm) and ERYTHEMA (redness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced FEELING HOT (Warm (ring) on skin), SWELLING (Swelling), INJECTION SITE MASS (Bump (L) arm) and ERYTHEMA (redness). The patient was treated with HYDROCORTISONE at a dose of UNK dosage form, bid and IBUPROFEN at a dose of UNK dosage form, bid. On 14-Feb-2021, FEELING HOT (Warm (ring) on skin), SWELLING (Swelling), INJECTION SITE MASS (Bump (L) arm) and ERYTHEMA (redness) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1559734
Sex: F
Age: 85
State: NC

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Numbness on the hand; Fatigue; Headache; Soreness of the injection spot; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness on the hand), FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness of the injection spot) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness on the hand), FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness of the injection spot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 07-Feb-2021, HYPOAESTHESIA (Numbness on the hand), FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness of the injection spot) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1559735
Sex: F
Age: 74
State: TN

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes under right arm/ Swelling of groin lymph nodes; experienced swelling of arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes under right arm/ Swelling of groin lymph nodes) and PERIPHERAL SWELLING (experienced swelling of arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. Concomitant products included TRAMADOL and PARACETAMOL (TYLENOL). On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PERIPHERAL SWELLING (experienced swelling of arm). On 29-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes under right arm/ Swelling of groin lymph nodes). The patient was treated with CELECOXIB (COXIB [CELECOXIB]) for Phlebitis, at an unspecified dose and frequency and HYDROCORTISONE ACETATE (CORTIZONE [HYDROCORTISONE ACETATE]) at an unspecified dose and frequency. On 31-Jan-2021, LYMPHADENOPATHY (Swollen lymph nodes under right arm/ Swelling of groin lymph nodes) had resolved. In July 2021, PERIPHERAL SWELLING (experienced swelling of arm) outcome was unknown. Not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided. Treatment mediations includes alcohol cortisone cream salve This case was linked to MOD-2021-029552 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Treatment medications updated.

Other Meds: TRAMADOL; TYLENOL

Current Illness:

ID: 1559736
Sex: M
Age: 54
State: TX

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 10-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments No concomitant medications were provided. No treatment information was reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.

Other Meds:

Current Illness:

ID: 1559737
Sex: F
Age: 69
State: FL

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Around the injection site, it's little warmth; Around the injection site, it's still red; Around the injection site, it's still itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Around the injection site, it's little warmth), VACCINATION SITE ERYTHEMA (Around the injection site, it's still red) and VACCINATION SITE PRURITUS (Around the injection site, it's still itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Around the injection site, it's little warmth), VACCINATION SITE ERYTHEMA (Around the injection site, it's still red) and VACCINATION SITE PRURITUS (Around the injection site, it's still itchy). At the time of the report, VACCINATION SITE WARMTH (Around the injection site, it's little warmth), VACCINATION SITE ERYTHEMA (Around the injection site, it's still red) and VACCINATION SITE PRURITUS (Around the injection site, it's still itchy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: TCR-event outcome, Patient endorsed she was feeling fine, and didn't want no further follow up

Other Meds:

Current Illness:

ID: 1559738
Sex: M
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ache from the Moderna shot; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Ache from the Moderna shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not Provided) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MYALGIA (Ache from the Moderna shot). At the time of the report, MYALGIA (Ache from the Moderna shot) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559739
Sex: M
Age: 87
State: SC

Vax Date: 02/22/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: almost fell; pale; very weak/loses power I start walking; very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (very weak/loses power I start walking), DIZZINESS (very dizzy), FALL (almost fell) and PALLOR (pale) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No medical history reported. Concomitant products included HYDROXYCARBAMIDE (HYDROXYUREA EURECO PHARMA) and WARFARIN for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced ASTHENIA (very weak/loses power I start walking), DIZZINESS (very dizzy), FALL (almost fell) and PALLOR (pale). At the time of the report, ASTHENIA (very weak/loses power I start walking), DIZZINESS (very dizzy), FALL (almost fell) and PALLOR (pale) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: HYDROXYUREA EURECO PHARMA; WARFARIN

Current Illness:

ID: 1559740
Sex: M
Age: 16
State: TX

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine not indicated; Sore arm; Pain at injection site; Headache; Body ache; Chills; Fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine not indicated), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache) and MYALGIA (Body ache) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 09-Feb-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine not indicated), VACCINATION SITE PAIN (Pain at injection site), HEADACHE (Headache), MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever). 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with EPINEPHRINE (EPIPEN) at a dose of 1 dosage form. On 09-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine not indicated) had resolved. On 12-Feb-2021, PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache), MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102-103 (High) high. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. It was reported that patient will not be given second dose. Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Added lab data. Added concomitant and treatment medications. Added second dose details of a patient. Added new events fever, sore arm. Updated reporter details. Updated patient details. Updated the time of first dose. Updated action taken. Updated event outcome. On 07-May-2021: Follow up information received on 07-MAY-2021 contains no new information.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old male) for mRNA-1273 (lot number 030M20A) with associated AEs reported as pain at injection site, headache, body pain, and chills.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1559741
Sex: F
Age: 68
State: FL

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Couldn't open her hands/ trouble maneuvering her wheelchair; Hands are very painful; This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Couldn't open her hands/ trouble maneuvering her wheelchair) and PAIN IN EXTREMITY (Hands are very painful) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Blood pressure high, High cholesterol, Food allergy and Amputee. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (Couldn't open her hands/ trouble maneuvering her wheelchair) and PAIN IN EXTREMITY (Hands are very painful). At the time of the report, JOINT RANGE OF MOTION DECREASED (Couldn't open her hands/ trouble maneuvering her wheelchair) and PAIN IN EXTREMITY (Hands are very painful) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness: Amputee; Blood pressure high; Diabetes; High cholesterol

ID: 1559742
Sex: F
Age:
State: FL

Vax Date: 02/12/2021
Onset Date: 02/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 2 red patches in arm; injection site pruritus; injection site swelling; injection site red blotch; injection site warmth; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site warmth), RASH (2 red patches in arm), INJECTION SITE PRURITUS (injection site pruritus), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (injection site red blotch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site warmth), INJECTION SITE PRURITUS (injection site pruritus), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (injection site red blotch). On 28-Feb-2021, the patient experienced RASH (2 red patches in arm). At the time of the report, VACCINATION SITE WARMTH (injection site warmth), RASH (2 red patches in arm), INJECTION SITE PRURITUS (injection site pruritus), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (injection site red blotch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559743
Sex: M
Age: 82
State: MI

Vax Date: 02/11/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got sick; All he wants to do is sleep; He has no appetite; He cannot get enough to drink; He cannot get warm; He does not feel like he can get up; Running a temperature of 101.8 F; He has chills real bad; He is just tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick), SOMNOLENCE (All he wants to do is sleep), DECREASED APPETITE (He has no appetite), DEHYDRATION (He cannot get enough to drink) and FEELING COLD (He cannot get warm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ILLNESS (Got sick). 13-Feb-2021, the patient experienced SOMNOLENCE (All he wants to do is sleep), DECREASED APPETITE (He has no appetite), DEHYDRATION (He cannot get enough to drink), FEELING COLD (He cannot get warm), ASTHENIA (He does not feel like he can get up), PYREXIA (Running a temperature of 101.8 F), CHILLS (He has chills real bad) and FATIGUE (He is just tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of Unknown. On 15-Feb-2021, PYREXIA (Running a temperature of 101.8 F) had resolved. On 16-Feb-2021, ILLNESS (Got sick), SOMNOLENCE (All he wants to do is sleep), DEHYDRATION (He cannot get enough to drink), FEELING COLD (He cannot get warm), ASTHENIA (He does not feel like he can get up) and CHILLS (He has chills real bad) had resolved. At the time of the report, DECREASED APPETITE (He has no appetite) and FATIGUE (He is just tired) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: 101.8 (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: added second dose

Other Meds:

Current Illness:

ID: 1559744
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: not feeling too well; not feeling good; chills; bone in her body is hurting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not feeling too well), FEELING ABNORMAL (not feeling good), CHILLS (chills) and BONE PAIN (bone in her body is hurting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (not feeling too well), FEELING ABNORMAL (not feeling good), CHILLS (chills) and BONE PAIN (bone in her body is hurting). At the time of the report, VACCINATION COMPLICATION (not feeling too well), FEELING ABNORMAL (not feeling good), CHILLS (chills) and BONE PAIN (bone in her body is hurting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559745
Sex: M
Age: 58
State: MA

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy; tired; body aches; headache; chills; arm hurt around shoulder; This spontaneous case was reported by a consumer and describes the occurrence of body aches, PAIN, HEADACHE, CHILLS, and AXILLARY PAIN in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included FUROSEMIDE, METOPROLOL, SOTALOL, ENTRESTO, CLONAZEPAM, PRAVASTATIN, VITAMIN D, ALLOPURINOL, FLOMAX, and FARXIGA for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN (body aches), HEADACHE, CHILLS, and AXILLARY PAIN. On 14-Feb-2021, the patient experienced PAIN and FATIGUE. The patient was treated with TYLENOL at a dose of 1 dosage form. At the time of the report, body aches, PAIN, HEADACHE, CHILLS, AXILLARY PAIN, and FATIGUE outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: FUROSEMIDE; METOPROLOL; SOTALOL; ENTRESTO; CLONAZEPAM; PRAVASTATIN; VITAMIN D; ALLOPURINOL; FLOMAX; FARXIGA

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm